rabbit anti relb Search Results


95
Bioss anti‑nf‑κb p65
Anti‑Nf‑κb P65, supplied by Bioss, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti‑nf‑κb p65/product/Bioss
Average 95 stars, based on 1 article reviews
anti‑nf‑κb p65 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

93
Novus Biologicals rabbit anti p p65 antibody
FIGURE 5 | The expression of PPARγ, <t>P65,</t> and p-P65 was altered in macrophages cultured in low glucose and hypoxia. (A) Representative electrophoretic bands showing the expression of PPARγ, P65 and p-P65 in control, CGS21680 and SCH58261 treated macrophages at post-culture. β-actin was used as internal control. (B) Statistical analysis showing the expression of PPARγ in macrophages was increased gradually in low glucose and hypoxic conditions, and was increased further by CGS21680 at post-culture 12 h, but SCH58261 reduced the expression of PPARγ at post-culture (ns: P > 0.05, ***P < 0.001. Two-way ANOVA test followed by Turkey’s multiple comparisons test. n = 3 independent experiments for each group). (C) Statistical analysis showing the expression of P65 was increased in macrophages at post-culture 12 and 24 h, and the expression was further increased by CGS21680 at 12 h and SCH58261 at 6 and 12 h (ns: P > 0.05, ***P < 0.001. Two-way ANOVA test followed by Turkey’s multiple comparisons test. n = 3 independent experiments for each group). (D) Statistical analysis showing the expression of p-P65 was increased by CGS21680 at post-culture 6 and 24 h, and was increased in SCH58261 treated macrophages at post-culture 6, 12, and 24 h (*P < 0.05, ***P < 0.001. Two-way ANOVA test followed by Turkey’s multiple comparisons test. n = 3 independent experiments for each group). (E,F) Statistical analysis showing the mRNA of PPARγ was increased in CGS21680 treated macrophages at 2 and 12 h, but not affected by SCH58261. The expression of P65 mRNA was increased in SCH58261 treated macrophages at post-culture 12 h (ns: P > 0.05, *P < 0.05, **P < 0.01, ***P < 0.001. Two-way ANOVA test followed by Turkey’s multiple comparisons test. n = 3 independent experiments for each group). ns, non significant; p >0.05.
Rabbit Anti P P65 Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti p p65 antibody/product/Novus Biologicals
Average 93 stars, based on 1 article reviews
rabbit anti p p65 antibody - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology p65
FIG. 6. IkB-a kinases specifically phosphorylate IkB-a but not c-Jun or the p50 or <t>p65</t> subunits of NF-kB. Cytoplasmic extracts were prepared from HUVEC monolayers stimulated with TNFa (300 units/ml) for 3 min. IkB-a kinases were purified from cytoplasmic extracts by an IkB-a-affinity method as described under “Materials and Methods.” Purified kinases were incubated with IkB-a (lane 3), p50 (lane 4), p65 (lane 5), MBP (lane 6), or c-Jun (lane 7) in a kinase reaction as described under “Materials and Methods.” As controls, kinase reac- tions were performed with IkB-a alone (lane 1) and with purified ki- nases alone (lane 2). A, Coomassie-stained SDS-PAGE gel. B, autora- diograph of A.
P65, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/p65/product/Santa Cruz Biotechnology
Average 96 stars, based on 1 article reviews
p65 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

99
Cell Signaling Technology Inc anti nfkb p65 rabbit
FIG. 6. IkB-a kinases specifically phosphorylate IkB-a but not c-Jun or the p50 or <t>p65</t> subunits of NF-kB. Cytoplasmic extracts were prepared from HUVEC monolayers stimulated with TNFa (300 units/ml) for 3 min. IkB-a kinases were purified from cytoplasmic extracts by an IkB-a-affinity method as described under “Materials and Methods.” Purified kinases were incubated with IkB-a (lane 3), p50 (lane 4), p65 (lane 5), MBP (lane 6), or c-Jun (lane 7) in a kinase reaction as described under “Materials and Methods.” As controls, kinase reac- tions were performed with IkB-a alone (lane 1) and with purified ki- nases alone (lane 2). A, Coomassie-stained SDS-PAGE gel. B, autora- diograph of A.
Anti Nfkb P65 Rabbit, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti nfkb p65 rabbit/product/Cell Signaling Technology Inc
Average 99 stars, based on 1 article reviews
anti nfkb p65 rabbit - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

90
Thermo Fisher phospho- nfκb (ser536, p65 antibody, rabbit monoclonal, 1:1,000, ca#ma5- 15160)
FIG. 6. IkB-a kinases specifically phosphorylate IkB-a but not c-Jun or the p50 or <t>p65</t> subunits of NF-kB. Cytoplasmic extracts were prepared from HUVEC monolayers stimulated with TNFa (300 units/ml) for 3 min. IkB-a kinases were purified from cytoplasmic extracts by an IkB-a-affinity method as described under “Materials and Methods.” Purified kinases were incubated with IkB-a (lane 3), p50 (lane 4), p65 (lane 5), MBP (lane 6), or c-Jun (lane 7) in a kinase reaction as described under “Materials and Methods.” As controls, kinase reac- tions were performed with IkB-a alone (lane 1) and with purified ki- nases alone (lane 2). A, Coomassie-stained SDS-PAGE gel. B, autora- diograph of A.
Phospho Nfκb (Ser536, P65 Antibody, Rabbit Monoclonal, 1:1,000, Ca#Ma5 15160), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phospho- nfκb (ser536, p65 antibody, rabbit monoclonal, 1:1,000, ca#ma5- 15160)/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
phospho- nfκb (ser536, p65 antibody, rabbit monoclonal, 1:1,000, ca#ma5- 15160) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

97
Cell Signaling Technology Inc anti nf κb p65 rabbit mab
Figure 4. The protein levels <t>of</t> <t>NF-κB</t> and phosphorylation of NF-κB. The protein levels 579
Anti Nf κb P65 Rabbit Mab, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti nf κb p65 rabbit mab/product/Cell Signaling Technology Inc
Average 97 stars, based on 1 article reviews
anti nf κb p65 rabbit mab - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

90
Beyotime rabbit anti-p65
Figure 4. The protein levels <t>of</t> <t>NF-κB</t> and phosphorylation of NF-κB. The protein levels 579
Rabbit Anti P65, supplied by Beyotime, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-p65/product/Beyotime
Average 90 stars, based on 1 article reviews
rabbit anti-p65 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

99
Cell Signaling Technology Inc anti p p65
Figure 4. The protein levels <t>of</t> <t>NF-κB</t> and phosphorylation of NF-κB. The protein levels 579
Anti P P65, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti p p65/product/Cell Signaling Technology Inc
Average 99 stars, based on 1 article reviews
anti p p65 - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

98
Cell Signaling Technology Inc phospho nf κb p65
Fig. 5 iOPN promoted STAT1-mediated immunosuppression in MSCs. a–d Vector-MSCs and iOPN-MSCs or WT-MSCs and OPN−/−-MSCs were treated with or without TNF-α plus IFN-γ (10 ng/mL) for the indicated times. Cells were harvested, and <t>OPN,</t> <t>NF-κB</t> <t>p65,</t> STAT1, IKBα, phosphorylation of NF-κB p65, phosphorylation of STAT1 at Tyr701 and phosphorylation of IKBα were analyzed by immunoblotting analysis. Full-length blots are presented in Additional file 1: Fig. 5a-d. e–g Vector-MSCs and iOPN-MSCs were stimulated with TNF-α plus IFN-γ (10 ng/mL) for 12 h. The STAT1 inhibitor fludarabine (Flu, 2 μM) was then added to the culture medium of Vector-MSCs and iOPN-MSCs. The expression of iNOS was determined by quantitative real-time PCR (e), immunoblotting analysis (f) and flow cytometry (g). Full-length blots are presented in Additional file 1: Fig. 5f. h Vector-MSCs and iOPN-MSCs were pretreated with DMSO or fludarabine (Flu, 2 μM) for 6 h and then irradiated and cocultured with CFSE-labeled splenocytes activated by anti-CD3/CD28 antibodies for 3 days at a ratio of 1:20. CD4+ T cells and CD8+ T cells were stained for proliferation analysis by flow cytometry at the end of coculture, and the percentages of proliferating T cells are shown. The results are representative of three to six independent experiments. Values are shown as the mean ± SEM and statistical significance is indicated as *P < 0.05, **P < 0.01 and ***P < 0.001
Phospho Nf κb P65, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phospho nf κb p65/product/Cell Signaling Technology Inc
Average 98 stars, based on 1 article reviews
phospho nf κb p65 - by Bioz Stars, 2026-03
98/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc rabbit anti relb
Fig. 5 iOPN promoted STAT1-mediated immunosuppression in MSCs. a–d Vector-MSCs and iOPN-MSCs or WT-MSCs and OPN−/−-MSCs were treated with or without TNF-α plus IFN-γ (10 ng/mL) for the indicated times. Cells were harvested, and <t>OPN,</t> <t>NF-κB</t> <t>p65,</t> STAT1, IKBα, phosphorylation of NF-κB p65, phosphorylation of STAT1 at Tyr701 and phosphorylation of IKBα were analyzed by immunoblotting analysis. Full-length blots are presented in Additional file 1: Fig. 5a-d. e–g Vector-MSCs and iOPN-MSCs were stimulated with TNF-α plus IFN-γ (10 ng/mL) for 12 h. The STAT1 inhibitor fludarabine (Flu, 2 μM) was then added to the culture medium of Vector-MSCs and iOPN-MSCs. The expression of iNOS was determined by quantitative real-time PCR (e), immunoblotting analysis (f) and flow cytometry (g). Full-length blots are presented in Additional file 1: Fig. 5f. h Vector-MSCs and iOPN-MSCs were pretreated with DMSO or fludarabine (Flu, 2 μM) for 6 h and then irradiated and cocultured with CFSE-labeled splenocytes activated by anti-CD3/CD28 antibodies for 3 days at a ratio of 1:20. CD4+ T cells and CD8+ T cells were stained for proliferation analysis by flow cytometry at the end of coculture, and the percentages of proliferating T cells are shown. The results are representative of three to six independent experiments. Values are shown as the mean ± SEM and statistical significance is indicated as *P < 0.05, **P < 0.01 and ***P < 0.001
Rabbit Anti Relb, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti relb/product/Cell Signaling Technology Inc
Average 94 stars, based on 1 article reviews
rabbit anti relb - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

90
ABclonal Biotechnology rabbit anti-phos pho-nf-κb p65 mab (ap1294)
Fig. 5 iOPN promoted STAT1-mediated immunosuppression in MSCs. a–d Vector-MSCs and iOPN-MSCs or WT-MSCs and OPN−/−-MSCs were treated with or without TNF-α plus IFN-γ (10 ng/mL) for the indicated times. Cells were harvested, and <t>OPN,</t> <t>NF-κB</t> <t>p65,</t> STAT1, IKBα, phosphorylation of NF-κB p65, phosphorylation of STAT1 at Tyr701 and phosphorylation of IKBα were analyzed by immunoblotting analysis. Full-length blots are presented in Additional file 1: Fig. 5a-d. e–g Vector-MSCs and iOPN-MSCs were stimulated with TNF-α plus IFN-γ (10 ng/mL) for 12 h. The STAT1 inhibitor fludarabine (Flu, 2 μM) was then added to the culture medium of Vector-MSCs and iOPN-MSCs. The expression of iNOS was determined by quantitative real-time PCR (e), immunoblotting analysis (f) and flow cytometry (g). Full-length blots are presented in Additional file 1: Fig. 5f. h Vector-MSCs and iOPN-MSCs were pretreated with DMSO or fludarabine (Flu, 2 μM) for 6 h and then irradiated and cocultured with CFSE-labeled splenocytes activated by anti-CD3/CD28 antibodies for 3 days at a ratio of 1:20. CD4+ T cells and CD8+ T cells were stained for proliferation analysis by flow cytometry at the end of coculture, and the percentages of proliferating T cells are shown. The results are representative of three to six independent experiments. Values are shown as the mean ± SEM and statistical significance is indicated as *P < 0.05, **P < 0.01 and ***P < 0.001
Rabbit Anti Phos Pho Nf κb P65 Mab (Ap1294), supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-phos pho-nf-κb p65 mab (ap1294)/product/ABclonal Biotechnology
Average 90 stars, based on 1 article reviews
rabbit anti-phos pho-nf-κb p65 mab (ap1294) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

97
Cell Signaling Technology Inc phospho p65
Figure 2 Signalling pathways activated after leptin and leptin plus IL-1 stimulation of chondrocytes and their role in collagenase expression. Primary human articular chondrocytes were serum starved overnight and then stimulated for 20 and 60 min with either leptin (25 µg/ml) or IL-1 (0.25 ng/ml) alone or in combination. Cells were lysed, and extracts immunoblotted with antibodies against (A) phospho-STAT1 (Y701 or S727), phospho-STAT3 (Y705 and S727), phospho-STAT5 (Y694) and β-tubulin as loading control; (B) phospho-Erk (p44/42) (T202/Y204 of Erk1), phospho-JNK (SAPK) (T183/Y185), phospho-p38 (T180/Y182); or (C) phospho-Akt (S473 and Y308) and <t>phospho-p65</t> (S536). (D and E) Primary human chondrocytes were stimulated with leptin (25 µg/ml) with or without the inhibitors, LY (LY249002, 5 µM), U0126 (5 µM), SB (SB203580, 10 µM), SP (SP600125, 10 µM), Akt IV (3 µM) or Akt VIII (3 µM) for 20 h. Cells were pretreated for 30 min with inhibitors or vehicle control before the addition of leptin. The expression of MMP1 (D) and MMP13 (E) was assayed by real-time reverse transcription PCR and expressed as fold relative to the control after normalisation to 18s rRNA. *p<0.05; **p<0.01; ***p<0.001 versus control. Data are representative of three separate experiments. IL, interleukin; MMP, matrix metalloproteinase.
Phospho P65, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/phospho p65/product/Cell Signaling Technology Inc
Average 97 stars, based on 1 article reviews
phospho p65 - by Bioz Stars, 2026-03
97/100 stars
  Buy from Supplier

Image Search Results


FIGURE 5 | The expression of PPARγ, P65, and p-P65 was altered in macrophages cultured in low glucose and hypoxia. (A) Representative electrophoretic bands showing the expression of PPARγ, P65 and p-P65 in control, CGS21680 and SCH58261 treated macrophages at post-culture. β-actin was used as internal control. (B) Statistical analysis showing the expression of PPARγ in macrophages was increased gradually in low glucose and hypoxic conditions, and was increased further by CGS21680 at post-culture 12 h, but SCH58261 reduced the expression of PPARγ at post-culture (ns: P > 0.05, ***P < 0.001. Two-way ANOVA test followed by Turkey’s multiple comparisons test. n = 3 independent experiments for each group). (C) Statistical analysis showing the expression of P65 was increased in macrophages at post-culture 12 and 24 h, and the expression was further increased by CGS21680 at 12 h and SCH58261 at 6 and 12 h (ns: P > 0.05, ***P < 0.001. Two-way ANOVA test followed by Turkey’s multiple comparisons test. n = 3 independent experiments for each group). (D) Statistical analysis showing the expression of p-P65 was increased by CGS21680 at post-culture 6 and 24 h, and was increased in SCH58261 treated macrophages at post-culture 6, 12, and 24 h (*P < 0.05, ***P < 0.001. Two-way ANOVA test followed by Turkey’s multiple comparisons test. n = 3 independent experiments for each group). (E,F) Statistical analysis showing the mRNA of PPARγ was increased in CGS21680 treated macrophages at 2 and 12 h, but not affected by SCH58261. The expression of P65 mRNA was increased in SCH58261 treated macrophages at post-culture 12 h (ns: P > 0.05, *P < 0.05, **P < 0.01, ***P < 0.001. Two-way ANOVA test followed by Turkey’s multiple comparisons test. n = 3 independent experiments for each group). ns, non significant; p >0.05.

Journal: Frontiers in aging neuroscience

Article Title: Adenosine A 2A Receptor in Bone Marrow-Derived Cells Mediated Macrophages M2 Polarization via PPARγ-P65 Pathway in Chronic Hypoperfusion Situation.

doi: 10.3389/fnagi.2021.792733

Figure Lengend Snippet: FIGURE 5 | The expression of PPARγ, P65, and p-P65 was altered in macrophages cultured in low glucose and hypoxia. (A) Representative electrophoretic bands showing the expression of PPARγ, P65 and p-P65 in control, CGS21680 and SCH58261 treated macrophages at post-culture. β-actin was used as internal control. (B) Statistical analysis showing the expression of PPARγ in macrophages was increased gradually in low glucose and hypoxic conditions, and was increased further by CGS21680 at post-culture 12 h, but SCH58261 reduced the expression of PPARγ at post-culture (ns: P > 0.05, ***P < 0.001. Two-way ANOVA test followed by Turkey’s multiple comparisons test. n = 3 independent experiments for each group). (C) Statistical analysis showing the expression of P65 was increased in macrophages at post-culture 12 and 24 h, and the expression was further increased by CGS21680 at 12 h and SCH58261 at 6 and 12 h (ns: P > 0.05, ***P < 0.001. Two-way ANOVA test followed by Turkey’s multiple comparisons test. n = 3 independent experiments for each group). (D) Statistical analysis showing the expression of p-P65 was increased by CGS21680 at post-culture 6 and 24 h, and was increased in SCH58261 treated macrophages at post-culture 6, 12, and 24 h (*P < 0.05, ***P < 0.001. Two-way ANOVA test followed by Turkey’s multiple comparisons test. n = 3 independent experiments for each group). (E,F) Statistical analysis showing the mRNA of PPARγ was increased in CGS21680 treated macrophages at 2 and 12 h, but not affected by SCH58261. The expression of P65 mRNA was increased in SCH58261 treated macrophages at post-culture 12 h (ns: P > 0.05, *P < 0.05, **P < 0.01, ***P < 0.001. Two-way ANOVA test followed by Turkey’s multiple comparisons test. n = 3 independent experiments for each group). ns, non significant; p >0.05.

Article Snippet: The membranes were blocked by 5% skimmed milk and incubated overnight at 4◦C with the following primary antibodies: a rabbit anti-PPARγ antibody (1:1000, AF6284, Affinity Bioscience, Beijing, China), rabbit anti-P65 antibody (1:1000, NB100-2176, NOVUS Biologicals, Building IV Centennial, CO 80112, USA), or rabbit anti-p-P65 antibody (1:1000, NB100-82088, NOVUS Biologicals, Building IV Centennial, CO 80112, USA).

Techniques: Expressing, Cell Culture, Control

FIGURE 7 | PPARγ regulated the expression of P65 and p-P65 in CGS21680 treated macrophages. (A) Representative electrophoretic bands showing the expression of P65 and p-P65 in PPARγ shRNA pre-transfected macrophages with or without CGS21680 treatment after cultured in low glucose and hypoxic conditions. (B,C) Densitometric analysis results showing the expression of P65 were reduced in shRNA targeted macrophages and further reduced by CGS21680 at post-culture 12 h (*P < 0.05, ***P < 0.001. Two-way ANOVA test followed by Turkey’s multiple comparisons test. n = 3 independent experiments for each group). (C) The ratio of p-P65/P65 was increased in macrophages upon PPARγ knockdown at post-culture 12 and 24 h, but was reduced in by additional CGS21680 treatment at post-culture 2 and 12 h (***P < 0.001. Two-way ANOVA test followed by Turkey’s multiple comparisons test. n = 3 independent experiments for each group). (D) RT-PCR results showing the mRNA expression of P65 was reduced in macrophages upon PPARγ knockdown at post-culture 12 h and was potentiated by additional CGS21680 treatment at post-culture 6 and 12 h (*P < 0.05, ***P < 0.001. Two-way ANOVA test followed by Turkey’s multiple comparisons test. n = 3 independent experiments for each group). **P < 0.01.

Journal: Frontiers in aging neuroscience

Article Title: Adenosine A 2A Receptor in Bone Marrow-Derived Cells Mediated Macrophages M2 Polarization via PPARγ-P65 Pathway in Chronic Hypoperfusion Situation.

doi: 10.3389/fnagi.2021.792733

Figure Lengend Snippet: FIGURE 7 | PPARγ regulated the expression of P65 and p-P65 in CGS21680 treated macrophages. (A) Representative electrophoretic bands showing the expression of P65 and p-P65 in PPARγ shRNA pre-transfected macrophages with or without CGS21680 treatment after cultured in low glucose and hypoxic conditions. (B,C) Densitometric analysis results showing the expression of P65 were reduced in shRNA targeted macrophages and further reduced by CGS21680 at post-culture 12 h (*P < 0.05, ***P < 0.001. Two-way ANOVA test followed by Turkey’s multiple comparisons test. n = 3 independent experiments for each group). (C) The ratio of p-P65/P65 was increased in macrophages upon PPARγ knockdown at post-culture 12 and 24 h, but was reduced in by additional CGS21680 treatment at post-culture 2 and 12 h (***P < 0.001. Two-way ANOVA test followed by Turkey’s multiple comparisons test. n = 3 independent experiments for each group). (D) RT-PCR results showing the mRNA expression of P65 was reduced in macrophages upon PPARγ knockdown at post-culture 12 h and was potentiated by additional CGS21680 treatment at post-culture 6 and 12 h (*P < 0.05, ***P < 0.001. Two-way ANOVA test followed by Turkey’s multiple comparisons test. n = 3 independent experiments for each group). **P < 0.01.

Article Snippet: The membranes were blocked by 5% skimmed milk and incubated overnight at 4◦C with the following primary antibodies: a rabbit anti-PPARγ antibody (1:1000, AF6284, Affinity Bioscience, Beijing, China), rabbit anti-P65 antibody (1:1000, NB100-2176, NOVUS Biologicals, Building IV Centennial, CO 80112, USA), or rabbit anti-p-P65 antibody (1:1000, NB100-82088, NOVUS Biologicals, Building IV Centennial, CO 80112, USA).

Techniques: Expressing, shRNA, Transfection, Cell Culture, Knockdown, Reverse Transcription Polymerase Chain Reaction

FIG. 6. IkB-a kinases specifically phosphorylate IkB-a but not c-Jun or the p50 or p65 subunits of NF-kB. Cytoplasmic extracts were prepared from HUVEC monolayers stimulated with TNFa (300 units/ml) for 3 min. IkB-a kinases were purified from cytoplasmic extracts by an IkB-a-affinity method as described under “Materials and Methods.” Purified kinases were incubated with IkB-a (lane 3), p50 (lane 4), p65 (lane 5), MBP (lane 6), or c-Jun (lane 7) in a kinase reaction as described under “Materials and Methods.” As controls, kinase reac- tions were performed with IkB-a alone (lane 1) and with purified ki- nases alone (lane 2). A, Coomassie-stained SDS-PAGE gel. B, autora- diograph of A.

Journal: The Journal of biological chemistry

Article Title: Identification of signal-induced IkappaB-alpha kinases in human endothelial cells.

doi: 10.1074/jbc.271.33.19680

Figure Lengend Snippet: FIG. 6. IkB-a kinases specifically phosphorylate IkB-a but not c-Jun or the p50 or p65 subunits of NF-kB. Cytoplasmic extracts were prepared from HUVEC monolayers stimulated with TNFa (300 units/ml) for 3 min. IkB-a kinases were purified from cytoplasmic extracts by an IkB-a-affinity method as described under “Materials and Methods.” Purified kinases were incubated with IkB-a (lane 3), p50 (lane 4), p65 (lane 5), MBP (lane 6), or c-Jun (lane 7) in a kinase reaction as described under “Materials and Methods.” As controls, kinase reac- tions were performed with IkB-a alone (lane 1) and with purified ki- nases alone (lane 2). A, Coomassie-stained SDS-PAGE gel. B, autora- diograph of A.

Article Snippet: Peptide-specific rabbit polyclonal antibodies against IkB-a, p50, and p65 were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).

Techniques: Purification, Incubation, Staining, SDS Page

Figure 4. The protein levels of NF-κB and phosphorylation of NF-κB. The protein levels 579

Journal: Microbes and infection

Article Title: CD38 deficiency up-regulated IL-1β and MCP-1 through TLR4/ERK/NF-κB pathway in sepsis pulmonary injury.

doi: 10.1016/j.micinf.2021.104845

Figure Lengend Snippet: Figure 4. The protein levels of NF-κB and phosphorylation of NF-κB. The protein levels 579

Article Snippet: The membrane was washed by TBST according to the manufacturer’s 164 instructions and incubated with anti-NF-κB p65 Rabbit mAb (1:1000) (CST, USA), 165 anti-Phospho-NF-κB p65 Rabbit mAb (1:500) (CST, USA), anti-NF-κB1 p105/p50 Rabbit 166 mAb (1:1000) (CST, USA), anti-Phospho-NF-κB p105 Rabbit mAb (1:500) (CST, USA), 167 anti-MAPK ERK1/2 Rabbit mAb (1:2000) (CST, USA), anti-Phospho-MAPK ERK1/2 168 Rabbit mAb (1:2000) (CST, USA), anti-MAPK JNK Rabbit mAb (1:2000) (CST, USA), 169 anti-Phospho-MAPK JNK Rabbit mAb (1:2000) (CST, USA), anti-MAPK p38 Rabbit mAb 170 (1:2000) (CST, USA), anti-Phospho-MAPK p38 Rabbit mAb (1:2000) (CST, USA), 171 anti-iNOS Rabbit mAb (1:1000) (CST, USA),anti-IL-1β Rabbit mAb (1:500) (Boster, China), 172 Jo urn al Pr e-p roo f anti-TNF-α Rabbit mAb (1:500) (Boster, China), anti-CCR2 Rabbit mAb (1:1000) (CST, 173 USA),anti-MCP-1 Rabbit mAb (1:1000) (CST, USA), and anti-GAPDH mAb (1:5000) 174 (Proteintech, USA).

Techniques: Phospho-proteomics

Fig. 5 iOPN promoted STAT1-mediated immunosuppression in MSCs. a–d Vector-MSCs and iOPN-MSCs or WT-MSCs and OPN−/−-MSCs were treated with or without TNF-α plus IFN-γ (10 ng/mL) for the indicated times. Cells were harvested, and OPN, NF-κB p65, STAT1, IKBα, phosphorylation of NF-κB p65, phosphorylation of STAT1 at Tyr701 and phosphorylation of IKBα were analyzed by immunoblotting analysis. Full-length blots are presented in Additional file 1: Fig. 5a-d. e–g Vector-MSCs and iOPN-MSCs were stimulated with TNF-α plus IFN-γ (10 ng/mL) for 12 h. The STAT1 inhibitor fludarabine (Flu, 2 μM) was then added to the culture medium of Vector-MSCs and iOPN-MSCs. The expression of iNOS was determined by quantitative real-time PCR (e), immunoblotting analysis (f) and flow cytometry (g). Full-length blots are presented in Additional file 1: Fig. 5f. h Vector-MSCs and iOPN-MSCs were pretreated with DMSO or fludarabine (Flu, 2 μM) for 6 h and then irradiated and cocultured with CFSE-labeled splenocytes activated by anti-CD3/CD28 antibodies for 3 days at a ratio of 1:20. CD4+ T cells and CD8+ T cells were stained for proliferation analysis by flow cytometry at the end of coculture, and the percentages of proliferating T cells are shown. The results are representative of three to six independent experiments. Values are shown as the mean ± SEM and statistical significance is indicated as *P < 0.05, **P < 0.01 and ***P < 0.001

Journal: Stem cell research & therapy

Article Title: Intracellular osteopontin potentiates the immunosuppressive activity of mesenchymal stromal cells.

doi: 10.1186/s13287-024-03979-8

Figure Lengend Snippet: Fig. 5 iOPN promoted STAT1-mediated immunosuppression in MSCs. a–d Vector-MSCs and iOPN-MSCs or WT-MSCs and OPN−/−-MSCs were treated with or without TNF-α plus IFN-γ (10 ng/mL) for the indicated times. Cells were harvested, and OPN, NF-κB p65, STAT1, IKBα, phosphorylation of NF-κB p65, phosphorylation of STAT1 at Tyr701 and phosphorylation of IKBα were analyzed by immunoblotting analysis. Full-length blots are presented in Additional file 1: Fig. 5a-d. e–g Vector-MSCs and iOPN-MSCs were stimulated with TNF-α plus IFN-γ (10 ng/mL) for 12 h. The STAT1 inhibitor fludarabine (Flu, 2 μM) was then added to the culture medium of Vector-MSCs and iOPN-MSCs. The expression of iNOS was determined by quantitative real-time PCR (e), immunoblotting analysis (f) and flow cytometry (g). Full-length blots are presented in Additional file 1: Fig. 5f. h Vector-MSCs and iOPN-MSCs were pretreated with DMSO or fludarabine (Flu, 2 μM) for 6 h and then irradiated and cocultured with CFSE-labeled splenocytes activated by anti-CD3/CD28 antibodies for 3 days at a ratio of 1:20. CD4+ T cells and CD8+ T cells were stained for proliferation analysis by flow cytometry at the end of coculture, and the percentages of proliferating T cells are shown. The results are representative of three to six independent experiments. Values are shown as the mean ± SEM and statistical significance is indicated as *P < 0.05, **P < 0.01 and ***P < 0.001

Article Snippet: Antibodies against GAPDH (CAT# 2118, RRID: AB_561053), NF-κB p65 (CAT# 8242, RRID:AB_10859369), phospho-NF-κB p65 (CAT# 3033, RRID:AB_331284), STAT1 (CAT# 14994, RRID:AB_2737027), phospho-STAT1 (Tyr701) (CAT# 7649, RRID:AB_10950970), IκBα (CAT# 4814, RRID:AB_390781), phospho-IκBα (CAT# 2118) and ubiquitin (CAT# 3936, RRID: RRID:AB_331292) were purchased from Cell Signaling Technology (Danvers, Massachusetts, USA).

Techniques: Plasmid Preparation, Phospho-proteomics, Western Blot, Expressing, Real-time Polymerase Chain Reaction, Flow Cytometry, Irradiation, Labeling, Staining

Figure 2 Signalling pathways activated after leptin and leptin plus IL-1 stimulation of chondrocytes and their role in collagenase expression. Primary human articular chondrocytes were serum starved overnight and then stimulated for 20 and 60 min with either leptin (25 µg/ml) or IL-1 (0.25 ng/ml) alone or in combination. Cells were lysed, and extracts immunoblotted with antibodies against (A) phospho-STAT1 (Y701 or S727), phospho-STAT3 (Y705 and S727), phospho-STAT5 (Y694) and β-tubulin as loading control; (B) phospho-Erk (p44/42) (T202/Y204 of Erk1), phospho-JNK (SAPK) (T183/Y185), phospho-p38 (T180/Y182); or (C) phospho-Akt (S473 and Y308) and phospho-p65 (S536). (D and E) Primary human chondrocytes were stimulated with leptin (25 µg/ml) with or without the inhibitors, LY (LY249002, 5 µM), U0126 (5 µM), SB (SB203580, 10 µM), SP (SP600125, 10 µM), Akt IV (3 µM) or Akt VIII (3 µM) for 20 h. Cells were pretreated for 30 min with inhibitors or vehicle control before the addition of leptin. The expression of MMP1 (D) and MMP13 (E) was assayed by real-time reverse transcription PCR and expressed as fold relative to the control after normalisation to 18s rRNA. *p<0.05; **p<0.01; ***p<0.001 versus control. Data are representative of three separate experiments. IL, interleukin; MMP, matrix metalloproteinase.

Journal: Annals of the rheumatic diseases

Article Title: Leptin produced by joint white adipose tissue induces cartilage degradation via upregulation and activation of matrix metalloproteinases.

doi: 10.1136/annrheumdis-2011-200372

Figure Lengend Snippet: Figure 2 Signalling pathways activated after leptin and leptin plus IL-1 stimulation of chondrocytes and their role in collagenase expression. Primary human articular chondrocytes were serum starved overnight and then stimulated for 20 and 60 min with either leptin (25 µg/ml) or IL-1 (0.25 ng/ml) alone or in combination. Cells were lysed, and extracts immunoblotted with antibodies against (A) phospho-STAT1 (Y701 or S727), phospho-STAT3 (Y705 and S727), phospho-STAT5 (Y694) and β-tubulin as loading control; (B) phospho-Erk (p44/42) (T202/Y204 of Erk1), phospho-JNK (SAPK) (T183/Y185), phospho-p38 (T180/Y182); or (C) phospho-Akt (S473 and Y308) and phospho-p65 (S536). (D and E) Primary human chondrocytes were stimulated with leptin (25 µg/ml) with or without the inhibitors, LY (LY249002, 5 µM), U0126 (5 µM), SB (SB203580, 10 µM), SP (SP600125, 10 µM), Akt IV (3 µM) or Akt VIII (3 µM) for 20 h. Cells were pretreated for 30 min with inhibitors or vehicle control before the addition of leptin. The expression of MMP1 (D) and MMP13 (E) was assayed by real-time reverse transcription PCR and expressed as fold relative to the control after normalisation to 18s rRNA. *p<0.05; **p<0.01; ***p<0.001 versus control. Data are representative of three separate experiments. IL, interleukin; MMP, matrix metalloproteinase.

Article Snippet: Primary antibodies against phospho-Erk1/2 (phospho-p44/42) (#9101), phospho-p38 (#9211), phosphoJNK1/2 (#9251), phospho-p65 (Ser 536; #3031) and phosphoSTAT were all from Cell Signaling Technology (New England Biolabs, Hitchin, UK).

Techniques: Expressing, Control, Reverse Transcription